Shanweite Biotechnology Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 2

Shanweite Biotechnology General Information

Description

Provider of oncology therapy research services intended for the development of innovative cancer treatments. The company provides synthetic biology and its proprietary YB1 oncolytic bacteria platform to develop tumor-targeted delivery systems and engineered bacterial injections, enabling clinical researchers and pharmaceutical firms to implement precise drug delivery and in situ therapeutic expression for the treatment of advanced solid tumors.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 501, 5th Floor, Building 9, Dongsheng Huigu
  • Number 1299 Kehai Avenue, Anchang Street, Keqiao District
  • Shaoxing, Zhejiang 312080
  • China
+86 186
Primary Industry
Drug Discovery
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Room 501, 5th Floor, Building 9, Dongsheng Huigu
  • Number 1299 Kehai Avenue, Anchang Street, Keqiao District
  • Shaoxing, Zhejiang 312080
  • China
+86 186

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Shanweite Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 02-Apr-2026 Completed Generating Revenue
1. Seed Round 15-Aug-2022 Completed Startup
To view Shanweite Biotechnology’s complete valuation and funding history, request access »

Shanweite Biotechnology Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
CAS Investment Management Growth/Expansion Minority
Lapam Capital Venture Capital Minority
To view Shanweite Biotechnology’s complete investors history, request access »

Ready to get started?

Request a free trial

Shanweite Biotechnology FAQs

  • When was Shanweite Biotechnology founded?

    Shanweite Biotechnology was founded in 2021.

  • Where is Shanweite Biotechnology headquartered?

    Shanweite Biotechnology is headquartered in Shaoxing, China.

  • What industry is Shanweite Biotechnology in?

    Shanweite Biotechnology’s primary industry is Drug Discovery.

  • Is Shanweite Biotechnology a private or public company?

    Shanweite Biotechnology is a Private company.

  • What is Shanweite Biotechnology’s current revenue?

    The current revenue for Shanweite Biotechnology is .

  • Who are Shanweite Biotechnology’s investors?

    CAS Investment Management and Lapam Capital have invested in Shanweite Biotechnology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process